🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 9 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/01/2017 18,31 19,67 16,59 17,73 -3,27% 16,82% 60.500
19/01/2017 19,04 19,79 18,09 18,33 -3,12% 8,93% 18.800
18/01/2017 19,82 19,82 18,66 18,92 -0,26% 5,85% 11.000
17/01/2017 19,41 19,75 18,01 18,97 -2,92% 8,96% 39.500
13/01/2017 18,91 19,81 18,31 19,54 +3,22% 7,93% 19.500
12/01/2017 19,40 19,72 18,03 18,93 -3,12% 8,68% 43.600
11/01/2017 20,09 20,09 19,27 19,54 -0,26% 4,08% 10.000
10/01/2017 20,32 20,32 19,43 19,59 -3,97% 4,38% 27.400
09/01/2017 20,52 21,80 20,09 20,40 -1,69% 8,33% 73.200
06/01/2017 21,23 21,58 20,59 20,75 -1,43% 4,66% 13.500
05/01/2017 20,70 21,61 20,40 21,05 -0,14% 5,85% 54.600
04/01/2017 21,40 21,60 21,00 21,08 -0,47% 2,80% 42.900
03/01/2017 22,26 22,50 20,89 21,18 -3,68% 7,23% 67.400
30/12/2016 22,21 22,39 21,57 21,99 -0,90% 3,69% 38.300
29/12/2016 22,08 22,29 21,75 22,19 +1,32% 2,46% 19.900
28/12/2016 22,52 22,54 21,50 21,90 -0,32% 4,62% 53.600
27/12/2016 22,14 22,40 21,68 21,97 +0,14% 3,27% 31.300
23/12/2016 21,75 22,03 21,74 21,94 +0,64% 1,31% 34.100
22/12/2016 22,02 22,30 21,30 21,80 -0,37% 4,54% 46.700
21/12/2016 22,95 23,01 21,39 21,88 -4,20% 7,06% 61.200
20/12/2016 22,60 23,20 22,23 22,84 +0,53% 4,29% 135.400
19/12/2016 23,29 23,35 21,91 22,72 -0,74% 6,18% 47.300
16/12/2016 21,59 23,65 21,36 22,89 +7,41% 10,61% 203.800
15/12/2016 20,49 22,07 19,70 21,31 +5,03% 11,57% 52.200
14/12/2016 20,05 20,85 19,67 20,29 +1,00% 5,89% 34.500
13/12/2016 20,23 20,57 20,03 20,09 -0,54% 2,65% 39.700
12/12/2016 21,81 21,81 19,26 20,20 -8,18% 11,69% 48.500
09/12/2016 22,86 22,97 21,75 22,00 -3,97% 5,34% 32.300
08/12/2016 25,58 25,78 21,62 22,91 -10,44% 16,24% 57.400
07/12/2016 25,76 26,00 24,86 25,58 -1,16% 4,44% 35.000